Literature DB >> 2615920

Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76.

C T Dourish1, E N Herbert, S D Iversen.   

Abstract

The effects of the putative, selective dopamine autoreceptor antagonist (+)-AJ 76 on yawning, penile grooming and mouth movements induced by small doses of apomorphine in male rats were examined. Yawning induced by 0.05mg/kg apomorphine was dose dependently blocked by (+)-AJ-76, significant decreases being observed at 0.86 and 3.5mg/kg of the drug. A dose of 0.86mg/kg (+)-AJ 76 caused a two fold shift to the right of the apomorphine dose response curve for yawning. In contrast, (+)-AJ 76 had no effect on penile grooming and vacuous mouth movements induced by small doses of apomorphine. This pattern of results is similar to that observed after bilateral 6-hydroxydopamine-induced lesions of the substantia nigra which also blocked apomorphine-induced yawning but spared penile grooming and mouth movements. Previous studies have suggested that (+)-AJ 76 is a selective dopamine autoreceptor antagonist that has little or no effect on behaviour mediated by post-synaptic dopamine receptors. Therefore, these data provide further support for the hypothesis that apomorphine-induced yawning is mediated by dopamine autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615920     DOI: 10.1016/0028-3908(89)90021-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  2 in total

1.  Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine.

Authors:  P M Callahan; M F Piercey; K A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.

Authors:  M Beltramo; F R de Fonseca; M Navarro; A Calignano; M A Gorriti; G Grammatikopoulos; A G Sadile; A Giuffrida; D Piomelli
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.